Checkpoint Therapeutics I... (CKPT)
NASDAQ: CKPT
· Real-Time Price · USD
4.26
0.00 (0.00%)
At close: May 29, 2025, 3:59 PM
Checkpoint Therapeutics Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -56.51M | -56.24M | -46.47M | -42.47M | -52.32M | -51.85M | -53.74M | -58.63M | -56.25M | -62.62M | -71.36M | -72.01M | -67.01M | -56.67M | -37.14M | -30.8M | -26.3M |
Depreciation & Amortization | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Stock-Based Compensation | 15.89M | 14.65M | 3.56M | 2.64M | 2.64M | 2.9M | 2.86M | 2.96M | 3.12M | 2.92M | 3.1M | 3.1M | 3.14M | 3.14M | 3M | 2.95M | 2.92M |
Other Working Capital | 284K | n/a | -875K | -589K | 281K | -1.6M | 1.62M | 1.24M | 4.63M | 6.36M | -2.84M | 1.06M | -46K | 818K | 7.55M | 2.12M | 1.39M |
Other Non-Cash Items | 8.13M | 5.58M | 10.11M | 8.86M | 9.02M | 4.15M | -1.85M | -110K | -852K | 6.75M | 6.94M | 6.96M | 7.19M | 7.63M | 5.65M | 6.34M | 6.15M |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | -1.4M | 1.97M | -901K | -6.27M | -2.31M | -2.79M | -3.33M | 3.06M | 2M | -4.61M | 9.58M | 15.18M | 15.43M | 19.6M | 6.73M | 1.3M | 570K |
Operating Cash Flow | -36.31M | -31.1M | -30.76M | -34.3M | -40.03M | -47.59M | -56.06M | -52.72M | -51.98M | -57.55M | -51.73M | -46.78M | -41.26M | -26.31M | -21.76M | -20.21M | -16.67M |
Capital Expenditures | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | 1.69M | 1.69M | 1.69M | -6K | -1.7M | -1.7M | -1.7M | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 46.11M | 6.78M | 7.69M | 7.83M | 6.31M | 6.83M | -5.64M | -4.76M | -3.25M | -2.73M | -326K | -336K | -523K | -1.01M | -1.33M | -2.8M | -2.62M |
Financial Cash Flow | 58.11M | 32.78M | 33.69M | 31.83M | 46.43M | 40.45M | 37.35M | 29.26M | 15.35M | 14.89M | 12.01M | 12.54M | 22.7M | 40.27M | 39.94M | 63.41M | 55.22M |
Net Cash Flow | 21.8M | 1.68M | 2.93M | -2.47M | 6.39M | -7.14M | -18.71M | -23.47M | -36.63M | -42.67M | -39.73M | -34.24M | -18.56M | 13.96M | 18.17M | 43.2M | 38.55M |
Free Cash Flow | -36.31M | -31.1M | -30.76M | -34.3M | -40.03M | -47.59M | -56.06M | -52.72M | -51.98M | -57.55M | -51.73M | -46.78M | -41.26M | -26.31M | -21.76M | -20.21M | -16.67M |